In 97 breast cancers, these authors found no Topo IIα gene copy aberrations when the Her-2/neu gene status was normal, yet when Her-2/neu was amplified, TOP2α was coamplifed in 44% and deleted in 42% of the cases. Here, ERBB2 is linked to breast carcinoma.